PROFILES - Connect with RTRN Researchers

Nawal M. Boukli
Title Director of Biomedical Proteomics Facility
Faculty Rank Full Professor
Degree Ph.D.
Institution Universidad Central Del Caribe
Department Microbiology and Immunology
Clusters Cancer
HIV/AIDS
Address
Department of Microbiology and Immunology
Universidad Central del Caribe
P.O. Box 60327, PR, USA
City Bayamon
State PR
Postal Code 00960
Telephone 787-798-3001 ext. 2080
Fax 787-740-4300
Email
QR Barcode

Awards and Honors icon

2005 San Juan Invited speaker, Addiction Technology Transfer Center Symposium. “Effect of the stress on the immu
2005 SANOFI-Aventis Invited speaker, high-throughput Proteomics: Protein Expression and Purification in the Postgenomi
2005 Natural Science Department, University of Puerto Rico, Aguadilla Keynote speaker: Fifth Student Scientific Research Symposium. “Proteomics in the Medical Field”
2006 National Hispanic Science Network on Drug Abuse 6th Annual Conference Presenter/Panel discussion member, Spoke about: “How to Develop Your Research Question”. Grant Wri
2009 Florida International University Invited speaker at the Institute of NeuroImmune Pharmacology
2018 Association of the Southeastern Association of Shared Resources (SEASR)/ABRF) Executive Board Member

Narrative icon

  Dr. Boukli is a Professor in the department of microbiology and immunology and is the Director of the Biomedical Proteomics Facility at the Universidad Central del Caribe, School of Medicine, PR, USA. Dr. Boukli got her Doctoral degree in Molecular Biology from the University of Geneva, Switzerland, where she worked in early molecular signaling events such as the type three secretion pathway in Rhyzobium bacteria. Dr. Boukli did her postdoctoral fellowship at the University of Missouri where she gained more expertise in proteomics technology. She then joined the Universidad Central Del Caribe where she organized a high-throughput Proteomic Core Facility. Dr. Boukli’s research uses the latest technologies, including quantitative proteomics multiplexing with isobaric tags approaches and molecular and flow cytometric analyses for the detection of biomarkers and molecular signatures in HIV, drug and alcohol of abuse, cancer and multiple sclerosis. Dr. Boukli has numerous peer-review articles and NIH funded grants on these and related topics. Dr. Boukli is also interested in how endoplasmic reticulum stress responses and cell fate decision can regulate the network of apoptotic and survival signal events in different cells and systems and the anti-cancer and anti-HIV mechanistic effects of natural compounds for cancer and HIV treatment as some of her publications demonstrate (Boukli et al, 2010, Boukli et al, 2011, Boukli et al, 2012, Rivera et al, and Boukli, 2016, Lopez et al, and Boukli, 2017, Rodriguez et al, and Boukli, 2018), see publications below).
In addition to her research pursuits, Dr. Boukli has been active in training young investigators, both individually (as a mentor and proteomics facility resource, post-doctoral fellows, medical students, Master and PhD trainees) and in the classroom (where she has developed a proteomics graduate-level course and several workshops on proteomics in clinical research). 


Language Skills:

• French (native)
• Arabic (native)
• English (Fluent, speaking, Fluent reading, Fluent writing)
• Spanish (Fluent, speaking, Fluent reading, Fluent writing)
• Italian (Fluent, speaking, Fluent reading, intermediate writing)

NIH Awarded Grants icon

  Research projects funded by the National Institutes of Health (NIH), the Centers for Disease Control (CDC), the Food and Drug Administration (FDA), and the Department of Veterans Affairs (VA)

Loading
Please wait
1.
2018RACIAL AND ETHNIC DISPARITIES IN HUMAN SERVICES ANALYSIS EXECUTION PROJECTHHSP233201500064I_HHSP23337020T
2.
2018MOTHER AND INFANT HOME VISITING PROGRAM EVALUATION, LONG-TERM FOLLOW-UP 2 (MIHOPE-LT2)HHSP233201500059I/ HHSP23337010T
3.
2018WHAT WORKS CLEARINGHOUSE OF PROVEN AND PROMISING APPROACHES TO MOVE WELFARE RECIPIENTS TO WORKHHSP233201500035I_HHSP23337034T
4.
2018HEAD START CONNECTS: INDIVIDUALIZING AND CONNECTS FAMILIES TO FAMILY SUPPORT SERVICESHHSP233201500059I/HHSP233201500059I
5.
2018ASSESSING MODELS OF COORDINATED SERVICES FOR LOW-INCOME CHILDREN AND THEIR FAMILIESHHSP233201500035I/HHSP23337028T
6.
2018CHILD CARE INTERSTATE BACKGROUND CHECKS (CC-IBACS)HHSP233201500045I
7.
2018 EARLY CARE AND EDUCATION LEADERSHIP STUDY (EXCELS)HHSP233201500035I / HHSP23337038T
8.
2017ASSESSMENT AND MAPPING OF COMMUNITY CONNECTIONS IN HOME VISITING (AMC-HV)HHSP233201500034I/HHSP23337002T
9.
2017A STRENGTHS-BASED APPROACH TO EXAMINING SUPPORTS FOR SELF-REGULATION SKILLS OF LATINO CHILDREN RAISED IN POVERTY90YR0104-01
10.
2017LEVERAGING HOME LANGUAGES TO PROMOTE EXECUTIVE FUNCTIONING90YR0103-01
11.
2017ADDRESSING THE NEEDS OF INFANTS AND TODDLERS EXPOSED TO MALTREATMENT: EXAMINING THE IMPACT OF AN INTEGRATED EARLY HEAD START & CHILDREN AND YOUTH SERVICES PROGRAM90YR0102-01
12.
2017EXPLORING THE RELATION BETWEEN POSITIVE BEHAVIOR SUPPORT AND LANGUAGE LEARNING OPPORTUNITIES IN PRESCHOOL CLASSROOMS.90YR0101-01
13.
2017CHILD MALTREATMENT INCIDENCE DATA LINKAGES (CMI DATA LINKAGES)HHSP233201500035I/HHSP23337022T
14.
2017IMPLEMENTATION AND ASSESSMENT OF COMPETENCIES FOR TEACHERS AND CAREGIVERS SERVING INFANTS AND TODDLERSHHSP233201500035I/HHSP23337021T
15.
2017HEAD START FAMILY AND CHILD EXPERIENCES SURVEY (FACES) 2019HHSP233201500035I/HHSP23337024T
16.
2017EVIDENCE BUILDING IN TANF: ADVANCING INNOVATIONS TO PROMOTE EMPLOYMENT AND ECONOMIC SECURITY FOR LOW-INCOME INDIVIDUALSHHSP233201500059I/HHSP23337006T
17.
2017OBSERVING SELF-REGULATION IN CONTEXT IN HEAD START CLASSROOMS AND DUAL LANGUAGE LEARNERS SCHOOL READINESS90YR0105-01
18.
2016FAMILY SELF-SUFFICIENCY DATA CENTER90PD0272-04
19.
2016DESIGN OPTIONS FOR HOME VISITING EVALUATION (DOHVE) 2.0HHSP233201500133I/HHSP23337002T
20.
2016DOMESTIC HUMAN TRAFFICKING AND THE CHILD WELFARE POPULATIONHHSP23320150039I/HHSP23337011T
21.
2016EVALUATION OF COACHING-FOCUSED INTERVENTIONS FOR HARD-TO-EMPLOY TANF CLIENTS AND OTHER LOW-INCOME POPULATIONSHHSP233201500035I/HHSP23337018T
22.
2016VARIATIONS IN IMPLEMENTATION OF QUALITY INTERVENTIONS: EXAMINING THE QUALITY-CHILD OUTCOMES RELATIONSHIP IN CHILD CARE AND EARLY EDUCATION (VIQI)HHSP233201500059I/HHSP23337002T
23.
2016CULTURE OF CONTINUOUS LEARNING PROJECT: A BREAKTHROUGH SERIES COLLABORATIVE FOR IMPROVING CHILD CARE AND HEAD START QUALITYHHSP233201500034I/HHSP23337001T
24.
2016EVALUATION OF THE NATIONAL HUMAN TRAFFICKING HOTLINE PROGRAMHHSP233201500039I/ HHSP23337007T
25.
2016ADVANCING WELFARE AND FAMILY SELF-SUFFICIENCY RESEARCH PROJECT (FOLLOW-ON) HHSP233201500035I/HHSP23337017T
26.
2016PROFESSIONAL DEVELOPMENT TOOLS TO IMPROVE THE QUALITY OF INFANT AND TODDLER CAREHHSP233201500035I/HHSP23337007T
27.
2016TRIBAL HOME VISITING EVALUATION INSTITUTEGS-10F-0204K/HHSP233201500114G
28.
2016BUILDING CAPACITY TO EVALUATE INTERVENTIONS FOR YOUTH/YOUNG ADULTS WITH CHILD WELFARE INVOLVEMENT AT-RISK OF HOMELESSNESS: PHASE IIHHSP233201500035I/HHSP23337013T
29.
2016HPOG UNIVERSITY PARTNERSHIPS 2.0 RESEARCH SUPPORTHHSP233201500071I/HHSP23337011T
30.
2016MULTI-SITE IMPLEMENTATION EVALUATION OF TRIBAL HOME VISITING (MUSE)HHSP233201500133I/HHSP23337004T
31.
2016EVALUATION OF GOAL-DIRECTED PSYCHOLOGICAL CAPITAL AND EMPLOYER COACHING IN HEALTH PROFESSION OPPORTUNITY DEVELOPMENT90HG1003-01
32.
2016ASSESSING THE EVIDENCE: HOME VISITING EVIDENCE OF EFFECTIVENESSGS-10F-0050L/HHSP233201500115G
33.
2016TWO-GENERATION APPROACHES TO IMPROVING FAMILY SELF-SUFFICIENCYHHSP233201500035I/HHSP23337003T
34.
2015PROMOTING SOCIAL COMPETENCE IN ECE: PREDICTING THE DEVELOPMENT OF PROSOCIAL BEHAVIOR FROM EARLY EXPERIENCES IN CHILD CARE AND FAMILIES90YE0168-01
35.
2015ARE HIGHER SUBSIDY PAYMENT RATES AND PROVIDER-FRIENDLY PAYMENT POLICIES ASSOCIATED WITH CHILD CARE QUALITY?90YE0177-01
36.
2015MITIGATING SUSCEPTIBILITY WITH THE CHILD CARE DEVELOPMENT FUND: USING FOUR LARGE DATA SETS TO CLASSIFY RISK PROFILES AND RISK TRANSMISSION BY MODIFIABLE FACTORS90YE0175-01
37.
2015CHILD CARE FACTORS THAT INFLUENCE PARENTAL ENGAGEMENT: UNDERSTANDING LONGITUDINAL PATHWAYS TO CHILDREN?S SCHOOL READINESS90YE0178-01
38.
2015SUHMRE: SAME-SEX RELATIONSHIPS: UPDATES TO HEALTHY MARRIAGE AND RELATIONSHIP EDUCATION PROGRAMMINGHHSP233201500064I/HHSP23337001T
39.
2015THE IMPACT OF EARLY CARE AND EDUCATION IN CHILD NUTRITION, SEDENTARY BEHAVIOR AND OBESITY BY KINDERGARTEN90YE0170-01
40.
2015HOW PARENTAL PREFERENCES AND SUBSIDY RECEIPT SHAPE IMMIGRANT FAMILIES? CHILD CARE CHOICES90YE0171-01
41.
2015SUPPORTING LOW-INCOME FAMILIES: STATE VARIATIONS IN CHILD CARE SUBSIDIES AND TANF POLICIES AND CHILDREN'S DEVELOPMENTAL ECOLOGIES90YE0173-01
42.
2015SUBSIDY UTILIZATION AND IMPACT ON EARLY CARE AND EDUCATION OF LOW-INCOME CHILDREN WITH SPECIAL NEEDS90YE0166-01
43.
2015CONSTELLATIONS OF SUPPORT: TEACHER PROFESSIONAL DEVELOPMENT IN HEAD START AND CHILD OUTCOMES90YE0179-01
44.
2015THE CHANGING LANDSCAPE OF PUBLICLY-FUNDED CENTER-BASED CHILD CARE: 1990 AND 2012.90YE0165-01
45.
2014IMPROVING CHILDREN?S WELL-BEING: IDENTIFYING MECHANISMS AND TIMING OF FAMILY STRENGTHENING PROGRAMS FOR LOW-INCOME FAMILIES THROUGH DIFFERENTIAL EQUATION MODELING90PD0285-01
46.
2014HOMELESS FAMILIES RESEARCH BRIEFSHHSP23320095624WC-01
47.
2014RESPONDING TO INTIMATE VIOLENCE IN RELATIONSHIP PROGRAMS (RIVIR)HHSP23320095651WC-01
48.
2014ASSESSING THE COST AND IMPLEMENTATION OF HIGH QUALITY EARLY CARE AND EDUCATION (ACIHQECE)HHSP23320095642WC-01
49.
2014CHILD CARE AND DEVELOPMENT FUND (CCDF) POLICIES DATABASE PROJECTHHSP23320095654WC-01
50.
2014INTERMEDIATE OUTCOMES OF CAREER PATHWAYS PROGRAMSHHSP233200956WC-01
51.
2014UNDERSTANDING THE INTERSECTION BETWEEN TANF AND REFUGEE CASH ASSISTANCE SERVICESHHSP23320095624WC-01
52.
2014EVALUATION OF DOMESTIC HUMAN TRAFFICKING DEMONSTRATION PROJECTSHHSP23320095651WC-01
53.
2013HUMAN SERVICES RESEARCH PARTNERSHIPS: PUERTO RICO 90YR0072-01
54.
2013MATERNAL, INFANT AND EARLY CHILDHOOD HOME VISITING EVALUATION (MIHOPE) IIHHSP23320095644WC-01
55.
2013CHILD CARE AND EARLY EDUCATION POLICY AND RESEARCH ANALYSES (CCEEPRA)HHSP23320095631WC-01
56.
2013JOB SEARCH ASSISTANCE EVALUATIONHHSP23320095624WC-01
57.
2013CHILD CARE ADMINISTRATIVE DATA ANALYSIS90YE0148-01
58.
2013EMPLOYMENT AND TRAINING EVIDENCE REVIEWHHSP23320095642WC-01
59.
2013STUDY OF EMPLOYMENT AND ADVANCEMENT OF RACIAL, ETHNIC AND LINGUISTIC MINORITIES90PH0021-02
60.
2013HEAD START UNIVERSITY PARTNERSHIPS: DUAL GENERATION APPROACHES90YR0075-01
61.
2013MOTHER AND INFANT HOME VISITING PROGRAM EVALUATION (MIHOPE)HHSP23337003T-03
62.
2013HEAD START UNIVERSITY PARTNERSHIPS: DUAL GENERATION APPROACHES90YR0073-01
63.
2013EARLY HEAD START-CHILD CARE PARTNERSHIPS STUDYHHSP23320095642WC-01

Publications icon

  Check NIH Public Access Policy Compliance

Loading
Please wait
1. Alves JM, Martins AH, Lameu C, Glaser T, Boukli NM, Bassaneze V, Dariolli R, Nascimento IC, Martins PCM, de Souza HDN, Krieger JE, Casarini DE, Sales VM, Pesquero JB, Ulrich H. Kinin-B2 Receptor Activity in Skeletal Muscle Regeneration and Myoblast Differentiation. Stem Cell Rev Rep. 2019 02; 15(1):48-58.
2. Valentín-Guillama G, López S, Kucheryavykh YV, Chorna NE, Pérez J, Ortiz-Rivera J, Inyushin M, Makarov V, Valentín-Acevedo A, Quinones-Hinojosa A, Boukli N, Kucheryavykh LY. HIV-1 Envelope Protein gp120 Promotes Proliferation and the Activation of Glycolysis in Glioma Cell. Cancers (Basel). 2018 Sep 01; 10(9).
3. Rodríguez-Valentín M, López S, Rivera M, Ríos-Olivares E, Cubano L, Boukli NM. Naturally Derived Anti-HIV Polysaccharide Peptide (PSP) Triggers a Toll-Like Receptor 4-Dependent Antiviral Immune Response. J Immunol Res. 2018; 2018:8741698.
4. López SN, Rodríguez-Valentín M, Rivera M, Rodríguez M, Babu M, Cubano LA, Xiong H, Wang G, Kucheryavykh L, Boukli NM. HIV-1 Gp120 clade B/C induces a GRP78 driven cytoprotective mechanism in astrocytoma. Oncotarget. 2017 Sep 15; 8(40):68415-68438.
5. Rivera M, Ramos Y, Rodríguez-Valentín M, López-Acevedo S, Cubano LA, Zou J, Zhang Q, Wang G, Boukli NM. Targeting multiple pro-apoptotic signaling pathways with curcumin in prostate cancer cells. PLoS One. 2017; 12(6):e0179587.
6. Sepúlveda-Torres LDC, Rishishwar L, Rogers ML, Ríos-Olivares E, Boukli N, Jordan IK, Cubano LA. A decade of viral mutations and associated drug resistance in a population of HIV-1+ Puerto Ricans: 2002-2011. PLoS One. 2017; 12(5):e0177452.
7. Burton LJ, Rivera M, Hawsawi O, Zou J, Hudson T, Wang G, Zhang Q, Cubano L, Boukli N, Odero-Marah V. Muscadine Grape Skin Extract Induces an Unfolded Protein Response-Mediated Autophagy in Prostate Cancer Cells: A TMT-Based Quantitative Proteomic Analysis. PLoS One. 2016; 11(10):e0164115.
8. Ricaurte M, Schizas NV, Ciborowski P, Boukli NM. Proteomic analysis of bleached and unbleached Acropora palmata, a threatened coral species of the Caribbean. Mar Pollut Bull. 2016 Jun 15; 107(1):224-232.
9. Soulié C, Fofana DB, Boukli N, Sayon S, Lambert-Niclot S, Wirden M, Simon A, Katlama C, Calvez V, Girard PM, Marcelin AG, Morand-Joubert L. Performance of genotypic algorithms for predicting tropism of HIV-1CRF02_AG subtype. J Clin Virol. 2016 Mar; 76:51-4.
10. Berríos VO, Boukli NM, Rodriguez JW, Negraes PD, Schwindt TT, Trujillo CA, Oliveira SL, Cubano LA, Ferchmin PA, Eterovic VA, Ulrich H, Martins AH. Paraoxon and Pyridostigmine Interfere with Neural Stem Cell Differentiation. Neurochem Res. 2015 Oct; 40(10):2091-101.
11. Yang J, Hu D, Xia J, Liu J, Zhang G, Gendelman HE, Boukli NM, Xiong H. Enhancement of NMDA receptor-mediated excitatory postsynaptic currents by gp120-treated macrophages: implications for HIV-1-associated neuropathology. J Neuroimmune Pharmacol. 2013 Sep; 8(4):921-33.
12. Miranda MT, Suárez E, Abbas M, Chinea A, Tosado R, Mejías IA, Boukli N, Dunston GM. HLA class I & II alleles in multiple sclerosis patients from Puerto Rico. Bol Asoc Med P R. 2013; 105(1):18-23.
13. Boukli NM, Shetty V, Cubano L, Ricaurte M, Coelho-Dos-Reis J, Nickens Z, Shah P, Talal AH, Philip R, Jain P. Unique and differential protein signatures within the mononuclear cells of HIV-1 and HCV mono-infected and co-infected patients. Clin Proteomics. 2012 Sep 07; 9(1):11.
14. Sepúlveda-Torres Ldel C, De La Rosa A, Cumba L, Boukli N, Ríos-Olivares E, Cubano LA. Prevalence of Drug Resistance and Associated Mutations in a Population of HIV-1(+) Puerto Ricans: 2006-2010. AIDS Res Treat. 2012; 2012:934041.
15. Mazzio EA, Boukli N, Rivera N, Soliman KF. Pericellular pH homeostasis is a primary function of the Warburg effect: inversion of metabolic systems to control lactate steady state in tumor cells. Cancer Sci. 2012 Mar; 103(3):422-32.
16. Kurapati KR, Samikkannu T, Kadiyala DB, Zainulabedin SM, Gandhi N, Sathaye SS, Indap MA, Boukli N, Rodriguez JW, Nair MP. Combinatorial cytotoxic effects of Curcuma longa and Zingiber officinale on the PC-3M prostate cancer cell line. J Basic Clin Physiol Pharmacol. 2012; 23(4):139-46.
17. Boukli NM, Delgado B, Ricaurte M, Espino AM. Fasciola hepatica and Schistosoma mansoni: identification of common proteins by comparative proteomic analysis. J Parasitol. 2011 Oct; 97(5):852-61.
18. Boukli NM, Saiyed ZM, Ricaurte M, Rodriguez JW, Ríos Olivares E, Cubano LA, Nair MP. Implications of ER stress, the unfolded protein response, and pro- and anti-apoptotic protein fingerprints in human monocyte-derived dendritic cells treated with alcohol. Alcohol Clin Exp Res. 2010 Dec; 34(12):2081-8.
19. Cubano LA, Cumba L, del Sepúlveda-Torres LC, Boukli N, Ríos-Olivares E. Prevalence of drug resistance and associated mutations in a population of Hiv-1+ Puerto Ricans in 2005. Bol Asoc Med P R. 2010 Jul-Sep; 102(3):13-7.
20. Nair MP, Saiyed ZM, Nair N, Gandhi NH, Rodriguez JW, Boukli N, Provencio-Vasquez E, Malow RM, Miguez-Burbano MJ. Methamphetamine enhances HIV-1 infectivity in monocyte derived dendritic cells. J Neuroimmune Pharmacol. 2009 Mar; 4(1):129-39.
21. Cubano LA, Sepúlveda-Torres Ldel C, Sosa G, Boukli N, Robles R, Rodriguez JW, Guzmán L, Ríos-Olivares E. Prevalence of drug resistance and associated mutations in HIV-positive Puerto Ricans: sex variations. Ethn Dis. 2008; 18(2 Suppl 2):S2-132-6.
22. Rodríguez JW, Pagan NO, Ocasio MC, Ríos Z, Cubano LA, Boukli NM, Otero M, Hunter R, Nair MP, Rios-Olivares E. Induction of a Soluble Anti-HIV-1 factor (s) with IFN-?, IL-10, and ß-Chemokine Modulating Activity by an Influenza-Bacterial Polyantigenic Mixture. Am J Infect Dis. 2007; 3(4).
23. Ríos-Olivares E, Vilá LM, Reyes JC, Rodríguez JW, Colón JH, Pagán NO, Marrero A, Ríos-Orraca ZM, Boukli NM, Shapshak P, Robles RR. Impaired cytokine production and suppressed lymphocyte proliferation activity in HCV-infected cocaine and heroin ("speedball") users. Drug Alcohol Depend. 2006 Dec 01; 85(3):236-43.
24. Boukli NM, Sunderasan E, Bartsev A, Hochstrasser D, Perret X, Bjourson AJ, Krause A, Broughton WJ. Early legume responses to inoculation with Rhizobium sp. NGR234. J Plant Physiol. 2007 Jun; 164(6):794-806.
25. Skorpil P, Saad MM, Boukli NM, Kobayashi H, Ares-Orpel F, Broughton WJ, Deakin WJ. NopP, a phosphorylated effector of Rhizobium sp. strain NGR234, is a major determinant of nodulation of the tropical legumes Flemingia congesta and Tephrosia vogelii. Mol Microbiol. 2005 Sep; 57(5):1304-17.
26. Launay O, Roudière L, Boukli N, Dupont B, Prévoteau du Clary F, Patey O, David F, Lortholary O, Devidas A, Piketty C, Rey E, Urbinelli R, Allaert FA, Tréluyer JM, Caumes E. Assessment of cetirizine, an antihistamine, to prevent cutaneous reactions to nevirapine therapy: results of the viramune-zyrtec double-blind, placebo-controlled trial. Clin Infect Dis. 2004 Apr 15; 38(8):e66-72.
27. Bartsev AV, Deakin WJ, Boukli NM, McAlvin CB, Stacey G, Malnoë P, Broughton WJ, Staehelin C. NopL, an effector protein of Rhizobium sp. NGR234, thwarts activation of plant defense reactions. Plant Physiol. 2004 Feb; 134(2):871-9.
28. Bartsev AV, Boukli NM, Deakin WJ, Staehelin C, Broughton WJ. Purification and phosphorylation of the effector protein NopL from Rhizobium sp. NGR234. FEBS Lett. 2003 Nov 20; 554(3):271-4.
29. Meynard JL, Guiguet M, Rachline A, Boukli N, Bollens D, Gentil C, Frottier J, Morand-Joubert L. [Predictive factors of virologic response to antiretroviral treatment with a protease inhibitor in HIV infection]. Presse Med. 2001 Jan 13; 30(1):5-10.
30. Salmon-Céron D, Mazeron MC, Chaput S, Boukli N, Senechal B, Houhou N, Katlama C, Matheron S, Fillet AM, Gozlan J, Leport C, Jeantils V, Freymuth F, Costagliola D. Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy. AIDS. 2000 May 26; 14(8):1041-9.

Abstracts icon

 

Loading
Please wait
1. Lariguet, P., Pankhurst, C.E., Porch, T., Silue, S., Boukli, N.M., Ishitani, M., Rao, I.M., Beebe, S., Triplett, E.W., Baudoin, J.P., Blair, M.W., and Broughton, W.J. . “Tilling Beans for Changes in Nodule and Seed Development as well as Tolerance to Aluminium”. In Proc. Phaseomics IV. 2005; 252:175-179.

Non-Print Materials icon

 

Loading
Please wait
1. Rao, K., Boukli, N., Samikkannu, T., Cubano, L., Dakshayani, K, Nair, M. . Profiling in PC-3M Prostate Cancer Cell Line and Cytotoxic Effects of Cucurma Longa. 2011.

Original Articles icon

 

Loading
Please wait
1. Rodríguez, J.W., Rodríguez, L.A., Font, G., Nieves, K., Cubano, L.A., Boukli, N., Otero, M., Hunter, R., Nair, M.P., and Ríos-Olivares, E. . Co-Expression of Apoptosis-Related Molecules on Activated CD8+CD38+ T-Cells is Associated with HIV-1 Disease Progression. American Journal of Infectious Disease. 2007; 4(3):208-216.
2. Boukli, N. M., Deakin, J.W., Kambara, K., Kobayashi, H., Marie, C., Perret, X., Le Quéré, A., Reuhs, B., Saad, M., Schumpp, O., Skorpil, P., Staehelin, C., Streit, W., and Broughton, W.J. . Springer Verlag, Berlin. “Rhizobial Control of Host-specificity”. Proceedings of the 14th International Congress on Nitrogen Fixation". 2005; 217-218.
3. Boukli, N.M., W.J. Deakin, K. Kambara, H. Kobayashi, C. Marie, X. Perret, A. Le Quéré, B. Reuhs*, M. Saad, O. Schumpp, P. Skorpil, C. Staehelin, W. Streit, & W.J. Broughton. . "Cell and Molecular Biology of Plant Root-Hairs". Springer-Verlag, Tokyo. 2004; 79-91.
4. Naturally Derived Anti-HIV Polysaccharide Peptide (PSP) Triggers a Toll-Like Receptor 4-Dependent Antiviral Immune Response.

Research Resources icon

Funding Opportunities icon

Browse active NIH & NSF funding opportunities, requests for applications (RFAs), and program announcements (PAs)